FDA Inspection 1259031 — Jeffery M. Adelglass, M.D.
The FDA completed an inspection of Jeffery M. Adelglass, M.D. on January 17, 2025 in Plano, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 17, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Plano, TX (United States)
Additional Details
Clinical Investigator (CI)